MIRA Pharmaceuticals, Inc.
MIRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,853 | -$11,982 | -$7,058 | -$2,177 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,551 | $1,297 | $0 |
| Change in WC | $371 | -$640 | $147 | $776 |
| Other Non-Cash | $1,921 | $5,539 | $10 | $24 |
| Operating Cash Flow | -$5,561 | -$4,532 | -$5,605 | -$1,376 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $1,005 | -$160 | $203 |
| Stock Issued | $3,609 | $7,704 | $2,904 | $4,500 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $182 | $74 | $402 | -$521 |
| Financing Cash Flow | $3,791 | $8,784 | $3,146 | $4,182 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,770 | $4,252 | -$2,459 | $2,806 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,603 | $351 | $2,810 | $3 |
| End Cash | $2,833 | $4,603 | $351 | $2,810 |
| Free Cash Flow | -$5,561 | -$4,532 | -$5,605 | -$1,376 |